DOCSLIB.ORG

(12) Patent Application Publication (10) Pub. No.: US 2014/0128289 A1 Gordon Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) Patent Application Publication (10) Pub. No.: US 2014/0128289 A1 Gordon Et Al US 2014.0128289A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0128289 A1 Gordon et al. (43) Pub. Date: May 8, 2014 (54) METHODS OF PROMOTING WEIGHT LOSS (60) Provisional application No. 61/076,887, filed on Jun. AND ASSOCATED ARRAYS 30, 2008, provisional application No. 61/101.011, filed on Sep. 29, 2008. (71) Applicant: The Washington University, St Louis, MO (US) Publication Classification (72) Inventors: Jeffrey I. Gordon, St. Louis, MO (US); (51) Int. C. Peter Turnbaugh, St. Louis, MO (US) CI2O I/68 (2006.01) GOIN33/569 (2006.01) (73) Assignee: The Washington University, St. Louis, (52) U.S. C. MO (US) CPC .......... CI2O 1/689 (2013.01); G0IN33/56911 (2013.01) (21) Appl. No.: 14/147,163 USPC ............................................... 506/16:506/18 (22) Filed: Jan. 3, 2014 (57) ABSTRACT Related U.S. Application Data The invention encompasses methods of modulating body fat (63) Continuation of application No. 13/002,137, filed on or weight loss. In addition, the invention encompasses arrays Mar. 29, 2011, now abandoned, filed as application that comprise biomolecules associated with an obese host No. PCT/US2009/049253 on Jun. 30, 2009. microbiome or a lean host microbiome. Second timepoit iitiative oint : Actrix:3cteria 8 is 888t::cieties 8xt::tiac:ria & 8ts: Patent Application Publication May 8, 2014 Sheet 1 of 50 US 2014/O128289 A1 SEE FIG 11 SEE FG 12 8 r: FG SEE FG 1.3 SEE FIG 1.4 SEE FG 15 Patent Application Publication May 8, 2014 Sheet 2 of 50 US 2014/O128289 A1 CONT. A FIG. 1.2 FIG 11 Patent Application Publication May 8, 2014 Sheet 3 of 50 US 2014/O128289 A1 CONT. FROM FIG. 1.1 CONT. AT FIG. 1.3 FIG 12 Patent Application Publication May 8, 2014 Sheet 4 of 50 US 2014/O128289 A1 CONT. FROM FIG. 1.2 CONT. ATFIG. 1.4 FIG 1.3 Patent Application Publication May 8, 2014 Sheet 5 of 50 US 2014/O128289 A1 CON. FROM FIG. 1.3 CONT. A FIG. 1.5 F.G. 14 Patent Application Publication May 8, 2014 Sheet 6 of 50 US 2014/O128289 A1 CONT. FROM FIG. 14 FIG 1.5 Patent Application Publication May 8, 2014 Sheet 7 of 50 US 2014/O128289 A1 A is a 8. 0.78 i 0.76 0.74 0.72 t, 3.88. 8. treated a Se: wit: yi-Yi 102 8 8.2. ea & Othese {{ 8. 88: { Nikitixer of sequences FIG 2 Patent Application Publication May 8, 2014 Sheet 8 of 50 US 2014/O128289 A1 A 0.66 raisiegt. s 8 3.8& 83 s: “s i 3 .8 *: i: .8 5 .8 3.38 featex ea: i: 888c: related C 16 v213 8.2 8 : 8. 88: t Nisixer of sexiences FIG 3 Patent Application Publication May 8, 2014 Sheet 9 of 50 US 2014/O128289 A1 Full-length 3.3. so too so 200 hitixer of seriences 28 it is 8 Nissaher of sequences FIG 3 Patent Application Publication May 8, 2014 Sheet 10 of 50 US 2014/O128289 A1 'l Full-length so o 150 Ninter of secuences FIG 3F Patent Application Publication May 8, 2014 Sheet 11 of 50 US 2014/O128289 A1 A 8. , - ,8. 8. ea e8: tireiaki &iate 0.81 .8 . .8 ..y . ses: sess treated reiated F.G. 4 Patent Application Publication May 8, 2014 Sheet 12 of 50 US 2014/O128289 A1 SEE FIG. 5, 1 SEE FIG 52 F.G. 5 SEE FIG 53 SEE FIG 54 SEE FIG 55 SEE FIG 5.6 Patent Application Publication May 8, 2014 Sheet 13 of 50 US 2014/O128289 A1 CONTAT FIG. 5.2 FIG 51 Patent Application Publication May 8, 2014 Sheet 14 of 50 US 2014/O128289 A1 CONT. FROM FIG. 5.1 3: 8:38: *:::::::::: &: CONT. A FIG. 5.3 FIG 52 Patent Application Publication May 8, 2014 Sheet 15 of 50 US 2014/O128289 A1 CONT. FROM FIG. 5.2 CON AT FIG. 5.4 FIG 53 Patent Application Publication May 8, 2014 Sheet 16 of 50 US 2014/O128289 A1 CONT. FROM FIG. 5.3 CONT. AT FIG. 5.5 F.G. 54 Patent Application Publication May 8, 2014 Sheet 17 of 50 US 2014/O128289 A1 CONT. FROM FIG. 5.4 FSX F: FE8 F8 Fly" CON. A FIG. 5.6 FIG 55 Patent Application Publication May 8, 2014 Sheet 18 of 50 US 2014/O128289 A1 CONT. FROM FIG. 5.5 FIG 56 Patent Application Publication May 8, 2014 Sheet 19 of 50 US 2014/O128289 A1 initia inepoint Second fiegint A O) o al as w 9 (0 Relative abundance (% of 16S rRNA sequences) : Actioacteria & ificates & Bacteroicieties : roteoacteria & their F G 6 Patent Application Publication May 8, 2014 Sheet 21 of 50 US 2014/O128289 A1 4.s8 83 ::::::: 88 it : : 283 : * 33 : 388 ft 38 : as : 8 83 it fisii gene s 20 30 40 50 60 70 80 90 % identity FIG 8 Patent Application Publication May 8, 2014 Sheet 22 of 50 US 2014/O128289 A1 se & 8 5 9 so s ce is 40 8 . $ox 20 20 30 40 50 . 60 to 80 90 100 .::::::::... E."8 Bit-score w:W 38 st ''''''-::::::::::::... 8 : 383 : : 3S D *:::::::: & * - & 83 : 883 : fisii ge:38 Patent Application Publication May 8, 2014 Sheet 23 of 50 US 2014/O128289 A1 E . 8 . 2 38 : 8 : 2 3. : s 80 o::...'... S8 : 8 s identityx (xx 238 : : 3 : : 3S : *::::::::::::::::::::::::::: $8 : 3 : 883 : . 8. ::::::. XX fu:ii ge:8 .& 4. www &::::::::::::::::::::::::::ors 2 3i 8 8 Bit-score F.G. 8 Patent Application Publication May 8, 2014 Sheet 24 of 50 US 2014/O128289 A1 * S3 st 8 : :...'...'. 33 x 23 : 288 it * 33 st * 388 it * & &Si : 883 : f: it ge:8 20 30 40 50 60 70 80 90 % identity F.G. 8 Patent Application Publication May 8, 2014 Sheet 25 of 50 US 2014/O128289 A1 8 8 .,. : , 203040 50 60708090 100 Bit-score * 8. it 8 : : ; it * 3: it * 3: . * : ; 38 38 ft fisii gene FIG 8 Patent Application Publication May 8, 2014 Sheet 26 of 50 US 2014/0128289 A1 Patent Application Publication May 8, 2014 Sheet 27 of 50 US 2014/O128289 A1 50 - x Baxteritietes c iricities so s5 60 65 to is 80 85 90 9s too ercept icientity tx reference gences FIG 10 Patent Application Publication May 8, 2014 Sheet 28 of 50 US 2014/O128289 A1 P.1 Leanloverweight F G. 11 Obese Ali pes putred is v2.1 1 6OOO 2 O Bacteroides Caccae v4.1 Bacteroides Ovatus v2.1 100 & 6 O 2 0. 3.... Bacteroides stercoris M Mb Patent Application Publication May 8, 2014 Sheet 29 of 50 US 2014/O128289 A1 P2 Lean/Overweight F G. 11 Obese Bacteroides thetaiotaOmicron WP15482 Bifidobacterium adolescentis v. Bifidobacterium longum NCC2705 OO 26OO 1 O O 6 O Mb Vb Patent Application Publication May 8, 2014 Sheet 30 of 50 US 2014/O128289 A1 P3 Lean/Overweight F G. 11 Obese Coinsella aerofaciens v3.1 Dorea longicatena v2.1 100 60 Eubacterium Siraeum W3. Faecalibacterium prausnitzii M21/2 v2.1 100 Methanobrevibacter Smithii ACC3506 Patent Application Publication May 8, 2014 Sheet 31 of 50 US 2014/O128289 A1 FIG 11 P4 Lean/Overweight Obese Bacteroides distasonis ATCC8503 100: 60 . s.s. s. s. s. s.s.. .s.. .s.. .s.. .s.......s. s. s. X ‘. 1 OO 2 O ---------- ------------ ---- -------- ----------- ------- Ruminococcus torques v2.1 100 Patent Application Publication May 8, 2014 Sheet 32 of 50 US 2014/O128289 A1 3MMMMMM $83 28 388 38 388 S8: 883d 88g: B 250 208 ise 88 88. 88: 28 388 48. 838 888 88.3888g: F.G. 12 Patent Application Publication May 8, 2014 Sheet 33 of 50 US 2014/O128289 A1 C 38 38 8. 88: s: 8: 3: 38 8 * 8 8: 288 388 400 388 888 8eai i8ng: 8 ce as as as see see 8888 icegis 883 8:8s:xxx: 8-ysisex: e-vau:8x8 8waii:8x8,xits carx88,%icietityx88 FIG 12 Patent Application Publication May 8, 2014 Sheet 34 of 50 US 2014/O128289 A1 PCR-based 16S rRNA gene sequences A is: & 88%. s s 88. s: $3. s & 3% w too% & 8 x & 8 & 8 & & : : x s : x & & X: . S . S . 3. 3. i. i. i. i. i. i. i. i. k . ii. iricites 88tergicieties Actioacteria geotacteria FIG 13 x tier Patent Application Publication May 8, 2014 Sheet 35 of 50 US 2014/O128289 A1 Vicrobione sequences : 88% 8. : 3% & - 888 8 88% s 88. & s : 28% F ; : : 88% 6.8% s: 3. S. &: 20% s:------: x& x8 x: x& x8 &: x : x3 x. :. x . .. .. .. .. .. itrictites acteroisiestes Actioacteria roteoacteria FG 13 x tier Patent Application Publication May 8, 2014 Sheet 36 of 50 US 2014/O128289 A1 :: *::::::::::::::::: 8:38. e :38 388 3:383 S28. $88. 88.8 8.33s. 3883: Scy 38: 88:8 2:38: Six: assists ass 88: F.G. 14A Patent Application Publication May 8, 2014 Sheet 37 of 50 US 2014/O128289 A1 B 100 8. (8. , 0.4. ), o2 3.4 s PC1 (20%) 0. 9. 9. 0. 9. 8 0.97 0.98 OS 5 0.94 Win WS Win WS Unrelated TWin Mor pairs FIG 14. Patent Application Publication May 8, 2014 Sheet 38 of 50 US 2014/O128289 A1 3.3 8.8 I 8. g 3:38: 3888 88: 88: 88: 88:38: 83f segsex8& FIG 15 Patent Application Publication May 8, 2014 Sheet 39 of 50 US 2014/O128289 A1 Patent Application Publication May 8, 2014 Sheet 40 of 50 US 2014/O128289 A1 Bacteroidetes Firmicutes GT CE CB CAZy families FG 16B Patent Application Publication May 8, 2014 Sheet 41 of 50 US 2014/O128289 A1 3A g $&##333333333 Patent Application Publication May 8, 2014 Sheet 42 of 50 US 2014/O128289 A1 Bacterial phy :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: S ir ices & 8actero i detes Actioacter a x.
Load more

Recommended publications
  • Uneven Distribution of Cobamide Biosynthesis and Dependence in Bacteria Predicted By
    bioRxiv preprint doi: https://doi.org/10.1101/342006; this version posted June 8, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Uneven distribution of cobamide biosynthesis and dependence in bacteria predicted by 2 comparative genomics 3 4 Running title: Cobamide biosynthesis predictions 5 6 Amanda N. Shelton1, Erica C. Seth1, Kenny C. Mok1, Andrew W. Han2, Samantha N. Jackson3,4, 7 David R. Haft3, Michiko E. Taga1* 8 9 1 Department of Plant & Microbial Biology, University of California, Berkeley, Berkeley, CA, 10 USA 11 2 Second Genome, Inc., South San Francisco, CA, USA 12 3 J. Craig Venter Institute, Rockville, MD, USA 13 4 Current address: Department of Biological & Environmental Engineering, Cornell University, 14 Ithaca, NY, USA 15 16 * Address correspondence to Michiko E. Taga, [email protected] 17 18 19 -- 20 Abstract 21 22 The vitamin B12 family of cofactors known as cobamides are essential for a variety of microbial 23 metabolisms. We used comparative genomics of 11,000 bacterial species to analyze the extent 1 bioRxiv preprint doi: https://doi.org/10.1101/342006; this version posted June 8, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 24 and distribution of cobamide production and use across bacteria.
    [Show full text]
  • Supporting Information
    Supporting Information Lozupone et al. 10.1073/pnas.0807339105 SI Methods nococcus, and Eubacterium grouped with members of other Determining the Environmental Distribution of Sequenced Genomes. named genera with high bootstrap support (Fig. 1A). One To obtain information on the lifestyle of the isolate and its reported member of the Bacteroidetes (Bacteroides capillosus) source, we looked at descriptive information from NCBI grouped firmly within the Firmicutes. This taxonomic error was (www.ncbi.nlm.nih.gov/genomes/lproks.cgi) and other related not surprising because gut isolates have often been classified as publications. We also determined which 16S rRNA-based envi- Bacteroides based on an obligate anaerobe, Gram-negative, ronmental surveys of microbial assemblages deposited near- nonsporulating phenotype alone (6, 7). A more recent 16S identical sequences in GenBank. We first downloaded the gbenv rRNA-based analysis of the genus Clostridium defined phylo- files from the NCBI ftp site on December 31, 2007, and used genetically related clusters (4, 5), and these designations were them to create a BLAST database. These files contain GenBank supported in our phylogenetic analysis of the Clostridium species in the HGMI pipeline. We thus designated these Clostridium records for the ENV database, a component of the nonredun- species, along with the species from other named genera that dant nucleotide database (nt) where 16S rRNA environmental cluster with them in bootstrap supported nodes, as being within survey data are deposited. GenBank records for hits with Ͼ98% these clusters. sequence identity over 400 bp to the 16S rRNA sequence of each of the 67 genomes were parsed to get a list of study titles Annotation of GTs and GHs.
    [Show full text]
  • The Isolation of Novel Lachnospiraceae Strains and the Evaluation of Their Potential Roles in Colonization Resistance Against Clostridium Difficile
    The isolation of novel Lachnospiraceae strains and the evaluation of their potential roles in colonization resistance against Clostridium difficile Diane Yuan Wang Honors Thesis in Biology Department of Ecology and Evolutionary Biology College of Literature, Science, & the Arts University of Michigan, Ann Arbor April 1st, 2014 Sponsor: Vincent B. Young, M.D., Ph.D. Associate Professor of Internal Medicine Associate Professor of Microbiology and Immunology Medical School Co-Sponsor: Aaron A. King, Ph.D. Associate Professor of Ecology & Evolutionary Associate Professor of Mathematics College of Literature, Science, & the Arts Reader: Blaise R. Boles, Ph.D. Assistant Professor of Molecular, Cellular and Developmental Biology College of Literature, Science, & the Arts 1 Table of Contents Abstract 3 Introduction 4 Clostridium difficile 4 Colonization Resistance 5 Lachnospiraceae 6 Objectives 7 Materials & Methods 9 Sample Collection 9 Bacterial Isolation and Selective Growth Conditions 9 Design of Lachnospiraceae 16S rRNA-encoding gene primers 9 DNA extraction and 16S ribosomal rRNA-encoding gene sequencing 10 Phylogenetic analyses 11 Direct inhibition 11 Bile salt hydrolase (BSH) detection 12 PCR assay for bile acid 7α-dehydroxylase detection 12 Tables & Figures Table 1 13 Table 2 15 Table 3 21 Table 4 25 Figure 1 16 Figure 2 19 Figure 3 20 Figure 4 24 Figure 5 26 Results 14 Isolation of novel Lachnospiraceae strains 14 Direct inhibition 17 Bile acid physiology 22 Discussion 27 Acknowledgments 33 References 34 2 Abstract Background: Antibiotic disruption of the gastrointestinal tract’s indigenous microbiota can lead to one of the most common nosocomial infections, Clostridium difficile, which has an annual cost exceeding $4.8 billion dollars.
    [Show full text]
  • Uneven Distribution of Cobamide Biosynthesis and Dependence in Bacteria Predicted by Comparative Genomics
    The ISME Journal (2018) 13:789–804 https://doi.org/10.1038/s41396-018-0304-9 ARTICLE Uneven distribution of cobamide biosynthesis and dependence in bacteria predicted by comparative genomics 1 1 1 1,2 3,4 3 Amanda N. Shelton ● Erica C. Seth ● Kenny C. Mok ● Andrew W. Han ● Samantha N. Jackson ● David R. Haft ● Michiko E. Taga1 Received: 7 June 2018 / Revised: 14 September 2018 / Accepted: 4 October 2018 / Published online: 14 November 2018 © The Author(s) 2018. This article is published with open access Abstract The vitamin B12 family of cofactors known as cobamides are essential for a variety of microbial metabolisms. We used comparative genomics of 11,000 bacterial species to analyze the extent and distribution of cobamide production and use across bacteria. We find that 86% of bacteria in this data set have at least one of 15 cobamide-dependent enzyme families, but only 37% are predicted to synthesize cobamides de novo. The distribution of cobamide biosynthesis and use vary at the phylum level. While 57% of Actinobacteria are predicted to biosynthesize cobamides, only 0.6% of Bacteroidetes have the complete pathway, yet 96% of species in this phylum have cobamide-dependent enzymes. The form of cobamide produced 1234567890();,: 1234567890();,: by the bacteria could be predicted for 58% of cobamide-producing species, based on the presence of signature lower ligand biosynthesis and attachment genes. Our predictions also revealed that 17% of bacteria have partial biosynthetic pathways, yet have the potential to salvage cobamide precursors. Bacteria with a partial cobamide biosynthesis pathway include those in a newly defined, experimentally verified category of bacteria lacking the first step in the biosynthesis pathway.
    [Show full text]
  • Characterization of an Endolysin Targeting Clostridioides Difficile
    International Journal of Molecular Sciences Article Characterization of an Endolysin Targeting Clostridioides difficile That Affects Spore Outgrowth Shakhinur Islam Mondal 1,2 , Arzuba Akter 3, Lorraine A. Draper 1,4 , R. Paul Ross 1 and Colin Hill 1,4,* 1 APC Microbiome Ireland, University College Cork, T12 YT20 Cork, Ireland; [email protected] (S.I.M.); [email protected] (L.A.D.); [email protected] (R.P.R.) 2 Genetic Engineering and Biotechnology Department, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh 3 Biochemistry and Molecular Biology Department, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh; [email protected] 4 School of Microbiology, University College Cork, T12 K8AF Cork, Ireland * Correspondence: [email protected] Abstract: Clostridioides difficile is a spore-forming enteric pathogen causing life-threatening diarrhoea and colitis. Microbial disruption caused by antibiotics has been linked with susceptibility to, and transmission and relapse of, C. difficile infection. Therefore, there is an urgent need for novel therapeutics that are effective in preventing C. difficile growth, spore germination, and outgrowth. In recent years bacteriophage-derived endolysins and their derivatives show promise as a novel class of antibacterial agents. In this study, we recombinantly expressed and characterized a cell wall hydrolase (CWH) lysin from C. difficile phage, phiMMP01. The full-length CWH displayed lytic activity against selected C. difficile strains. However, removing the N-terminal cell wall binding domain, creating CWH351—656, resulted in increased and/or an expanded lytic spectrum of activity. C. difficile specificity was retained versus commensal clostridia and other bacterial species.
    [Show full text]
  • The Mechanisms of in Vivo Commensal Control of C
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.04.894915; this version posted January 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. The mechanisms of in vivo commensal control of C. difficile virulence Title: The mechanisms of in vivo commensal control of Clostridioides difficile virulence Authors: Girinathan BP1*, DiBenedetto N1*, Worley J1,2, Peltier J3§, Lavin R4, Delaney ML1,5, Cummins C1, Onderdonk AB1,5, Gerber GK1,6,, Dupuy B3, Sonenshein AL4, Bry L1,5,** Abstract: We define multiple mechanisms by which commensals protect against or worsen Clostridioides difficile infection. Using a systems-level approach we show how two species of Clostridia with distinct metabolic capabilities modulate the pathogen’s virulence to impact host survival. Gnotobiotic mice colonized with the amino acid fermenter Clostridium bifermentans survived infection, while colonization with the butyrate-producer, Clostridium sardiniense, more rapidly succumbed. Systematic in vivo analyses revealed how each commensal altered the pathogen’s carbon source metabolism, cellular machinery, stress responses, and toxin production. Protective effects were replicated in infected conventional mice receiving C. bifermentans as an oral bacteriotherapeutic that prevented lethal infection. Leveraging a systematic and organism-level approach to host-commensal- pathogen interactions in vivo, we lay the groundwork for mechanistically-informed therapies to treat and prevent this disease. Author Affiliations: 1. Massachusetts Host-Microbiome Center, Dept. Pathology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA 2.
    [Show full text]
  • Depression and Microbiome—Study on the Relation and Contiguity Between Dogs and Humans
    applied sciences Article Depression and Microbiome—Study on the Relation and Contiguity between Dogs and Humans Elisabetta Mondo 1,*, Alessandra De Cesare 1, Gerardo Manfreda 2, Claudia Sala 3 , Giuseppe Cascio 1, Pier Attilio Accorsi 1, Giovanna Marliani 1 and Massimo Cocchi 1 1 Department of Veterinary Medical Science, University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano Emilia, Italy; [email protected] (A.D.C.); [email protected] (G.C.); [email protected] (P.A.A.); [email protected] (G.M.); [email protected] (M.C.) 2 Department of Agricultural and Food Sciences, University of Bologna, Via del Florio 2, 40064 Ozzano Emilia, Italy; [email protected] 3 Department of Physics and Astronomy, Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-051-209-7329 Received: 22 November 2019; Accepted: 7 January 2020; Published: 13 January 2020 Abstract: Behavioral studies demonstrate that not only humans, but all other animals including dogs, can suffer from depression. A quantitative molecular evaluation of fatty acids in human and animal platelets has already evidenced similarities between people suffering from depression and German Shepherds, suggesting that domestication has led dogs to be similar to humans. In order to verify whether humans and dogs suffering from similar pathologies also share similar microorganisms at the intestinal level, in this study the gut-microbiota composition of 12 German Shepherds was compared to that of 15 dogs belonging to mixed breeds which do not suffer from depression. Moreover, the relation between the microbiota of the German Shepherd’s group and that of patients with depression has been investigated.
    [Show full text]
  • Chronic Diarrhea, Bile Acids, and Clostridia
    Chronic diarrhea, bile acids, and Clostridia Julian R.F. Walters, Julian R. Marchesi J Clin Invest. 2020;130(1):77-79. https://doi.org/10.1172/JCI133117. Commentary Excessive fecal bile acid (BA) loss causes symptoms in a large proportion of people diagnosed with irritable bowel syndrome with diarrhea, a common functional bowel disorder. This BA diarrhea (BAD) results from increased hepatic synthesis of BAs, with impaired negative feedback regulation by the ileal hormone fibroblast growth factor 19 (FGF19). In this issue of the JCI, Zhao et al. investigated BA metabolism, including fecal BAs, serum BAs, and FGF19, in patients and controls. They identified associations between fecal bacterial BA metabolism and specific microbiota, especially Clostridium scindens. These findings have been tested in a mouse model using microbiota transplants and antibiotic treatment. This group of organisms has potential as a biomarker for BAD and to be a target for therapy. Find the latest version: https://jci.me/133117/pdf The Journal of Clinical Investigation COMMENTARY Chronic diarrhea, bile acids, and Clostridia Julian R.F. Walters1,2 and Julian R. Marchesi1,3 1Division of Digestive Diseases, Department of Metabolism, Digestion, and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom. 2Gastroenterology, Division of Medicine and Integrated Care, Imperial College Healthcare NHS Trust, London, United Kingdom. 3School of Biosciences, Cardiff University, Cardiff, United Kingdom. A possible cause of PBAD Excessive fecal bile acid (BA) loss causes symptoms in a large proportion In this issue of the JCI, Zhao et al. investi- gated the relevance of the BA/FXR signal- of people diagnosed with irritable bowel syndrome with diarrhea, a ing pathway and the effects of microbial common functional bowel disorder.
    [Show full text]
  • Updates on the Sporulation Process in Clostridium Species
    Updates on the sporulation process in Clostridium species Talukdar, P. K., Olguín-Araneda, V., Alnoman, M., Paredes-Sabja, D., & Sarker, M. R. (2015). Updates on the sporulation process in Clostridium species. Research in Microbiology, 166(4), 225-235. doi:10.1016/j.resmic.2014.12.001 10.1016/j.resmic.2014.12.001 Elsevier Accepted Manuscript http://cdss.library.oregonstate.edu/sa-termsofuse *Manuscript 1 Review article for publication in special issue: Genetics of toxigenic Clostridia 2 3 Updates on the sporulation process in Clostridium species 4 5 Prabhat K. Talukdar1, 2, Valeria Olguín-Araneda3, Maryam Alnoman1, 2, Daniel Paredes-Sabja1, 3, 6 Mahfuzur R. Sarker1, 2. 7 8 1Department of Biomedical Sciences, College of Veterinary Medicine and 2Department of 9 Microbiology, College of Science, Oregon State University, Corvallis, OR. U.S.A; 3Laboratorio 10 de Mecanismos de Patogénesis Bacteriana, Departamento de Ciencias Biológicas, Facultad de 11 Ciencias Biológicas, Universidad Andrés Bello, Santiago, Chile. 12 13 14 Running Title: Clostridium spore formation. 15 16 17 Key Words: Clostridium, spores, sporulation, Spo0A, sigma factors 18 19 20 Corresponding author: Dr. Mahfuzur Sarker, Department of Biomedical Sciences, College of 21 Veterinary Medicine, Oregon State University, 216 Dryden Hall, Corvallis, OR 97331. Tel: 541- 22 737-6918; Fax: 541-737-2730; e-mail: [email protected] 23 1 24 25 Abstract 26 Sporulation is an important strategy for certain bacterial species within the phylum Firmicutes to 27 survive longer periods of time in adverse conditions. All spore-forming bacteria have two phases 28 in their life; the vegetative form, where they can maintain all metabolic activities and replicate to 29 increase numbers, and the spore form, where no metabolic activities exist.
    [Show full text]
  • Functional Genomic Examinations of Interactions Between Common Members of the Umh an Gut Microbiota Michael Mahowald Washington University in St
    Washington University in St. Louis Washington University Open Scholarship All Theses and Dissertations (ETDs) January 2010 Functional Genomic Examinations Of Interactions Between Common Members Of The umH an Gut Microbiota Michael Mahowald Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/etd Recommended Citation Mahowald, Michael, "Functional Genomic Examinations Of Interactions Between Common Members Of The umH an Gut Microbiota" (2010). All Theses and Dissertations (ETDs). 222. https://openscholarship.wustl.edu/etd/222 This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has been accepted for inclusion in All Theses and Dissertations (ETDs) by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY Division of Biology and Biomedical Sciences Molecular Microbiology and Microbial Pathogenesis Dissertation Examination Committee: Jeffrey I. Gordon, Chair Douglas E. Berg Michael G. Caparon Daniel E. Goldberg Elaine R. Mardis Clay F. Semenkovich FUNCTIONAL GENOMIC EXAMINATIONS OF INTERACTIONS BETWEEN COMMON MEMBERS OF THE HUMAN GUT MICROBIOTA by Michael Anthony Mahowald A dissertation presented to the Graduate School of Arts and Sciences of Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy May 2010 Saint Louis, Missouri Copyright by Michael Anthony Mahowald 2010 Dedication To my parents, Anthony P. and Mary Briody Mahowald ii ABSTRACT OF THE DISSERTATION Functional genomic examinations of interactions between common members of the human gut microbiota by Michael Anthony Mahowald Doctor of Philosophy in Biology and Biomedical Sciences (Molecular Microbiology and Microbial Pathogenesis) Washington University in St.
    [Show full text]
  • Assignment of Eubacterium Sp. VPI 12708
    International Journal of Systematic and Evolutionary Microbiology (2000), 50, 971–978 Printed in Great Britain Assignment of Eubacterium sp. VPI 12708 and related strains with high bile acid 7α- dehydroxylating activity to Clostridium scindens and proposal of Clostridium hylemonae sp. nov., isolated from human faeces Maki Kitahara,1 Fusae Takamine,2 Teisuke Imamura2 and Yoshimi Benno1 Author for correspondence: Maki Kitahara. Tel: j81 48 4679562. Fax: j81 48 462 4619. e-mail: kitahara!jcm.riken.go.jp 1 Japan Collection of Unknown Eubacterium-like organisms VPI 12708 and five strains (Y-1113, I-10, Microorganisms, RIKEN, M-18, TH-82 and 36S) had high bile acid 7α-dehydroxylating activity; the Wako, Saitama 351-0198, T Japan unknown Clostridium-like organisms TN-271 and TN-272 also had the same activity. Analysis of their 16S rDNA sequences demonstrated that all strains 2 Laboratory of Microbiology, School of belong to cluster XIVa of the genus Clostridium (Collins et al., 1994). Strain VPI Health Sciences, Faculty of 12708 and five other strains (Y-1113, I-10, M-18, TH-82 and 36S) formed a single Medicine, University of the cluster and strains TN-271T and TN-272 formed another single cluster. Ryukyus, Okinawa T 903-0215, Japan Clostridium scindens JCM 6567 was the most closely related species for two clusters in the phylogenetic tree. Values for DNA–DNA similarities among C. scindens JCM 6567T, strain VPI 12708 and the other five strains were greater than 70%, showing that these micro-organisms were a single species. Therefore, we identified strain VPI 12708 and the five other strains as C.
    [Show full text]
  • Staff Advice Report
    Staff Advice Report 11 January 2021 Advice to the Decision-making Committee to determine the new organism status of 18 gut bacteria species Application code: APP204098 Application type and sub-type: Statutory determination Applicant: PSI-CRO Date application received: 4 December 2020 Purpose of the Application: Information to support the consideration of the determination of 18 gut bacteria species Executive Summary On 4 December 2020, the Environmental Protection Authority (EPA) formally received an application from PSI-CRO requesting a statutory determination of 18 gut bacteria species, Anaerotruncus colihominis, Blautia obeum (aka Ruminococcus obeum), Blautia wexlerae, Enterocloster aldenensis (aka Clostridium aldenense), Enterocloster bolteae (aka Clostridium bolteae), Clostridium innocuum, Clostridium leptum, Clostridium scindens, Clostridium symbiosum, Eisenbergiella tayi, Emergencia timonensis, Flavonifractor plautii, Holdemania filiformis, Intestinimonas butyriciproducens, Roseburia hominis, ATCC PTA-126855, ATCC PTA-126856, and ATCC PTA-126857. In absence of publicly available data on the gut microbiome from New Zealand, the applicant provided evidence of the presence of these bacteria in human guts from the United States, Europe and Australia. The broad distribution of the species in human guts supports the global distribution of these gut bacteria worldwide. After reviewing the information provided by the applicant and found in scientific literature, EPA staff recommend the Hazardous Substances and New Organisms (HSNO) Decision-making Committee (the Committee) to determine that the 18 bacteria are not new organisms for the purpose of the HSNO Act. Recommendation 1. Based on the information available, the bacteria appear to be globally ubiquitous and commonly identified in environments that are also found in New Zealand (human guts). 2.
    [Show full text]